Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gemma Kenter
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Living Beings
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
49
Fleuren, Gert Jan
26
Trimbos, Baptist
20
van der Burg, Sjoerd
20
Melief, Cornelis
17
Offringa, Rienk
13
Gorter, Arko
11
Gaarenstroom, Katja
11
Drijfhout, Jan Wouter
11
Jordanova, Ekaterina
10
Kwappenberg, Kitty
9
van der Hulst, Jeanette
8
Peters, A A W
8
Welters, Marij
7
Maas, Cornelis
6
Hermans, Jo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gemma Kenter (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kenter Gemma G; Welters Marij J P; Valentijn A Rob P M; Lowik Margriet J G; Berends-van der Meer Dorien M A; Vloon Annelies P G; Essahsah Farah; Fathers Lorraine M; Offringa Rienk; Drijfhout Jan Wouter; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; van der Burg Sjoerd H; Melief Cornelis J M
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
The New England journal of medicine 2009;361(19):1838-47.
-
2009: Karim Rezaul; Jordanova Ekaterina S; Piersma Sytse J; Kenter Gemma G; Chen Lieping; Boer Judith M; Melief Cornelis J M; van der Burg Sjoerd H
Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(20):6341-7.
-
2009: Mehta Akash M; Jordanova Ekaterina S; Corver Willem E; van Wezel Tom; Uh Hae-Won; Kenter Gemma G; Jan Fleuren Gert
Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma.
Genes, chromosomes & cancer 2009;48(5):410-8.
-
2009: van den Tillaart Sabrina A H M; Kenter Gemma G; Peters Alexander A W; Dekker Friedo W; Gaarenstroom Katja N; Fleuren Gertjan J; Trimbos J Baptist M Z
Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(1):39-45.
-
2008: de Vos van Steenwijk Peggy J; Piersma Sytse J; Welters Marij J P; van der Hulst Jeanette M; Fleuren Gertjan; Hellebrekers Bart W J; Kenter Gemma G; van der Burg Sjoerd H
Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7188-95.
-
2008: Kloth Judith N; Kenter Gemma G; Spijker H Siebe; Uljee Sandra; Corver Willem E; Jordanova Ekaterina S; Fleuren Gert Jan; Gorter Arko
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(7):866-75.
-
2008: van den Hende Muriel; van Poelgeest Mariëtte I E; van der Hulst Jeanette M; de Jong Joan; Drijfhout Jan W; Fleuren Gert Jan; Valentijn A Rob P M; Wafelman Amon R; Slappendel Gijs M; Melief Cornelis J M; Offringa Rienk; van der Burg Sjoerd H; Kenter Gemma G
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
International journal of cancer. Journal international du cancer 2008;123(1):146-52.
-
2008: Pieterse Q D; Ter Kuile M M; Maas C P; Kenter G G
The Gynaecologic Leiden Questionnaire: psychometric properties of a self-report questionnaire of sexual function and vaginal changes for gynaecological cancer patients.
Psycho-oncology 2008;17(7):681-9.
-
2008: Pieterse Q D; Kenter G G; Eilers P H C; Trimbos J B M Z
An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):432-8.
-
2008: Pieterse Q D; Ter Kuile M M; Deruiter M C; Trimbos J B M Z; Kenter G G; Maas C P
Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):576-83.
-
2008: Jordanova Ekaterina S; Gorter Arko; Ayachi Ouissam; Prins Frans; Durrant Lindy G; Kenter Gemma G; van der Burg Sjoerd H; Fleuren Gert Jan
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2028-35.
-
2008: Sier Cornelis F M; Hawinkels Lukas J A C; Zijlmans Henry J M A A; Zuidwijk Kim; de Jonge-Muller Eveline S M; Ferreira Valérie; Hanemaaijer Roeland; Mulder-Stapel Adri A; Kenter Gemma G; Verspaget Hein W; Gorter Arko
Endothelium specific matrilysin (MMP-7) expression in human cancers.
Matrix biology : journal of the International Society for Matrix Biology 2008;27(3):267-71.
-
2008: Piersma Sytse J; Welters Marij J P; van der Hulst Jeanette M; Kloth Judith N; Kwappenberg Kitty M C; Trimbos Baptist J; Melief Cornelis J M; Hellebrekers Bart W; Fleuren Gert Jan; Kenter Gemma G; Offringa Rienk; van der Burg Sjoerd H
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
International journal of cancer. Journal international du cancer 2008;122(3):486-94.
-
2008: Mehta Akash M; Jordanova Ekaterina S; Kenter Gemma G; Ferrone Soldano; Fleuren Gert-Jan
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Cancer immunology, immunotherapy : CII 2008;57(2):197-206.
-
2008: Welters Marij J P; Kenter Gemma G; Piersma Sytse J; Vloon Annelies P G; Löwik Margriet J G; Berends-van der Meer Dorien M A; Drijfhout Jan W; Valentijn A Rob P M; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; Offringa Rienk; Melief Cornelis J M; van der Burg Sjoerd H
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):178-87.
-
2008: Kenter Gemma G; Welters Marij J P; Valentijn A Rob P M; Lowik Margriet J G; Berends-van der Meer Dorien M A; Vloon Annelies P G; Drijfhout Jan W; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; Offringa Rienk; van der Burg Sjoerd H; Melief Cornelis J M
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):169-77.
-
2008: Kloth Judith N; Gorter Arko; ter Haar Natalja; Corver Willem E; Jordanova Ekaterina S; Kenter Gemma G; Fleuren Gert Jan
Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
Molecular immunology 2008;45(1):152-9.
-
2007: de Boer Marjon A; Jordanova Ekaterina S; van Poelgeest Mariëtte I E; van den Akker Brendy E; van der Burg Sjoerd H; Kenter Gemma G; Fleuren Gert Jan
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
International journal of cancer. Journal international du cancer 2007;121(12):2711-5.
-
2007: van der Burg Sjoerd H; Piersma Sytse J; de Jong Annemieke; van der Hulst Jeanette M; Kwappenberg Kitty M C; van den Hende Muriel; Welters Marij J P; Van Rood Jon J; Fleuren Gert Jan; Melief Cornelis J M; Kenter Gemma G; Offringa Rienk
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(29):12087-92.
-
2007: Hazelbag S; Kenter G G; Gorter A; Dreef E J; Koopman L A; Violette S M; Weinreb P H; Fleuren G J
Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
The Journal of pathology 2007;212(3):316-24.
-
2007: Mehta Akash M; Jordanova Ekaterina S; van Wezel Tom; Uh Hae-Won; Corver Willem E; Kwappenberg Kitty M C; Verduijn Willem; Kenter Gemma G; van der Burg Sjoerd H; Fleuren Gert J
Genetic variation of antigen processing machinery components and association with cervical carcinoma.
Genes, chromosomes & cancer 2007;46(6):577-86.
-
2007: Jacobi Catharina E; van Ierland Yvette; van Asperen Christi J; Hallensleben Eric; Devilee Peter; Jan Fleuren Gert; Kenter Gemma G
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(3):173-9.
-
2007: Pieterse Q D; Kenter G G; Gaarenstroom K N; Peters A A W; Willems S M; Fleuren G J; Trimbos J B M Z
The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(2):216-21.
-
2007: Zijlmans Henry J M A A; Fleuren Gert Jan; Baelde Hans J; Eilers Paul H C; Kenter Gemma G; Gorter Arko
Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
Cancer 2007;109(3):556-65.
-
2007: Piersma Sytse J; Jordanova Ekaterina S; van Poelgeest Mariëtte I E; Kwappenberg Kitty M C; van der Hulst Jeanette M; Drijfhout Jan W; Melief Cornelis J M; Kenter Gemma G; Fleuren Gert Jan; Offringa Rienk; van der Burg Sjoerd H
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Cancer research 2007;67(1):354-61.
-
2007: de Boer Marjon A; Jordanova Ekaterina S; Kenter Gemma G; Peters Alexander A; Corver Willem E; Trimbos J Baptist; Fleuren Gert Jan
High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):132-8.
-
2007: Kloth Judith N; Oosting Jan; van Wezel Tom; Szuhai Karoly; Knijnenburg Jeroen; Gorter Arko; Kenter Gemma G; Fleuren Gert Jan; Jordanova Ekaterina S
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
BMC genomics 2007;8():53.
-
2006: Green J A; Berns E M J J; Coens C; van Luijk I; Thompson-Hehir J; van Diest P; Verheijen R H M; van de Vijver M; van Dam P; Kenter G G; Tjalma W; Ewing P C; Teodorovic I; Vergote I; van der Burg M E L;
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).
European journal of cancer (Oxford, England : 1990) 2006;42(15):2539-48.
-
2006: Sier Cornelis F M; Zuidwijk Kim; Zijlmans Henry J M A A; Hanemaaijer Roeland; Mulder-Stapel Adri A; Prins Frans A; Dreef Enno J; Kenter Gemma G; Fleuren Gert Jan; Gorter Arko
EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
International journal of cancer. Journal international du cancer 2006;118(12):2991-8.
-
2006: Pieterse Q D; Maas C P; ter Kuile M M; Lowik M; van Eijkeren M A; Trimbos J B M Z; Kenter G G
An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1119-29.
-
2006: Pieterse Q D; Trimbos J B M Z; Dijkman A; Creutzberg C L; Gaarenstroom K N; Peters A A W; Kenter G G
Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1112-8.
-
2006: Zijlmans H J M A A; Fleuren G J; Baelde H J; Eilers P H C; Kenter G G; Gorter A
The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.
The Journal of pathology 2006;208(4):507-17.
-
2006: Welters Marij J P; van der Logt Pauline; van den Eeden Susan J F; Kwappenberg Kitty M C; Drijfhout Jan Wouter; Fleuren Gert Jan; Kenter Gemma G; Melief Cornelis J M; van der Burg Sjoerd H; Offringa Rienk
Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.
International journal of cancer. Journal international du cancer 2006;118(4):950-6.
-
2006: van Poelgeest Mariëtte I E; Nijhuis Esther R; Kwappenberg Kitty M C; Hamming Ineke E; Wouter Drijfhout Jan; Fleuren Gert Jan; van der Zee Ate G J; Melief Cornelis J M; Kenter Gemma G; Nijman Hans W; Offringa Rienk; van der Burg Sjoerd H
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.
International journal of cancer. Journal international du cancer 2006;118(3):675-83.
-
2006: Gaarenstroom K N; van der Hiel B; Tollenaar R A E M; Vink G R; Jansen F W; van Asperen C J; Kenter G G
Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():54-9.
-
2005: Maas Cornelis P; Kenter Gemma G; Trimbos J Baptist; Deruiter Marco C
Anatomical basis for nerve-sparing radical hysterectomy: immunohistochemical study of the pelvic autonomic nerves.
Acta obstetricia et gynecologica Scandinavica 2005;84(9):868-74.
-
2005: Kloth Judith N; Fleuren Gert Jan; Oosting Jan; de Menezes Renee X; Eilers Paul H C; Kenter Gemma G; Gorter Arko
Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Carcinogenesis 2005;26(9):1493-502.
-
2005: van Poelgeest Mariëtte I E; van Seters Manon; van Beurden Marc; Kwappenberg Kitty M C; Heijmans-Antonissen Claudia; Drijfhout Jan W; Melief Cornelis J M; Kenter Gemma G; Helmerhorst Theo J M; Offringa Rienk; van der Burg Sjoerd H
Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5273-80.
-
2005: de Jong Annemieke; van der Hulst Jeanette M; Kenter Gemma G; Drijfhout Jan Wouter; Franken Kees L M C; Vermeij Pieter; Offringa Rienk; van der Burg Sjoerd H; Melief Cornelis J M
Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.
International journal of cancer. Journal international du cancer 2005;114(2):274-82.
-
2005: Crijnen Th E M; Janssen-Heijnen M L G; Gelderblom H; Morreau J; Nooij M A; Kenter G G; Vasen H F A
Survival of patients with ovarian cancer due to a mismatch repair defect.
Familial cancer 2005;4(4):301-5.
-
2004: Hazelbag Suzanne; Kenter Gemma G; Gorter Arko; Fleuren Gert Jan
Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
International journal of cancer. Journal international du cancer 2004;112(6):1020-8.
-
2004: Trimbos J B; Lambeek A F; Peters A A W; Wolterbeek R; Gaarenstroom K N; Fleuren G J; Kenter G G
Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer.
Gynecologic oncology 2004;95(1):77-81.
-
2004: Ferber Matthew J; Eilers Paul; Schuuring Ed; Fenton James A L; Fleuren Gert Jan; Kenter Gemma; Szuhai Károly; Smith David I; Raap Anton K; Brink Antoinette A T P
Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Cancer genetics and cytogenetics 2004;154(1):1-9.
-
2004: de Jong Annemieke; van Poelgeest Mariëtte I E; van der Hulst Jeanette M; Drijfhout Jan Wouter; Fleuren Gert Jan; Melief Cornelis J M; Kenter Gemma; Offringa Rienk; van der Burg Sjoerd H
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.
Cancer research 2004;64(15):5449-55.
-
2004: Hendriks Yvonne M C; Wagner Anja; Morreau Hans; Menko Fred; Stormorken Astrid; Quehenberger Franz; Sandkuijl Lodewijk; Møller Pal; Genuardi Maurizio; Van Houwelingen Hans; Tops Carli; Van Puijenbroek Marjo; Verkuijlen Paul; Kenter Gemma; Van Mil Anneke; Meijers-Heijboer Hanne; Tan Gita B; Breuning Martijn H; Fodde Riccardo; Wijnen Juul Th; Bröcker-Vriends Annette H J T; Vasen Hans
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.
Gastroenterology 2004;127(1):17-25.
-
2004: Maas C P; ter Kuile M M; Laan E; Tuijnman C C; Weijenborg Ph Th M; Trimbos J B; Kenter G G
Objective assessment of sexual arousal in women with a history of hysterectomy.
BJOG : an international journal of obstetrics and gynaecology 2004;111(5):456-62.
-
2003: Maas C P; Trimbos J B; DeRuiter M C; van de Velde C J H; Kenter G G
Nerve sparing radical hysterectomy: latest developments and historical perspective.
Critical reviews in oncology/hematology 2003;48(3):271-9.
-
2003: Gaarenstroom K N; Kenter G G; Trimbos J B; Agous I; Amant F; Peters A A W; Vergote I
Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(4):522-7.
-
2003: Trimbos J B; Maas C P; Deruiter M C; Kenter G G
[Nerve sparing radical hysterectomy in the case of cervical cancer]
Nederlands tijdschrift voor geneeskunde 2003;147(28):1344-7.
-
2003: Maas Cornelis P; Kenter Gemma G; Trimbos Baptist
Outcomes after total versus subtotal abdominal hysterectomy.
The New England journal of medicine 2003;348(9):856-7; author reply 856-7.
-
2003: Welters Marij J P; de Jong Annemieke; van den Eeden Susan J F; van der Hulst Jeanette M; Kwappenberg Kitty M C; Hassane Sabrin; Franken Kees L M C; Drijfhout Jan Wouter; Fleuren Gert Jan; Kenter Gemma; Melief Cornelis J M; Offringa Rienk; van der Burg Sjoerd H
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
Cancer research 2003;63(3):636-41.
-
2002: Hazelbag Suzanne; Gorter Arko; Kenter Gemma G; van den Broek Lambert; Fleuren Gertjan
Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Human pathology 2002;33(12):1193-9.
-
2002: Boks Dominique E S; Trujillo Aliana P; Voogd Adri C; Morreau Hans; Kenter Gemma G; Vasen Hans F A
Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer.
International journal of cancer. Journal international du cancer 2002;102(2):198-200.
-
2002: Kenter G G; Heintz A P M
Surgical treatment of low stage cervical carcinoma: back to the old days?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(5):429-34.
-
2002: Brink Antoinette A T P; Wiegant Joop C A G; Szuhai Károly; Tanke Hans J; Kenter Gemma G; Fleuren Gert-Jan; Schuuring Ed; Raap Anton K
Simultaneous mapping of human papillomavirus integration sites and molecular karyotyping in short-term cultures of cervical carcinomas by using 49-color combined binary ratio labeling fluorescence in situ hybridization.
Cancer genetics and cytogenetics 2002;134(2):145-50.
-
2002: Dove-Edwin Isis; Boks Dominique; Goff Sheila; Kenter Gemma G; Carpenter Robert; Vasen Hans F A; Thomas Huw J W
The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.
Cancer 2002;94(6):1708-12.
-
2002: de Jong Annemieke; van der Burg Sjoerd H; Kwappenberg Kitty M C; van der Hulst Jeanette M; Franken Kees L M C; Geluk Annemieke; van Meijgaarden Krista E; Drijfhout Jan Wouter; Kenter Gemma; Vermeij Pieter; Melief Cornelis J M; Offringa Rienk
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
Cancer research 2002;62(2):472-9.
-
2001: Hazelbag S; Fleuren G J; Baelde J J; Schuuring E; Kenter G G; Gorter A
Cytokine profile of cervical cancer cells.
Gynecologic oncology 2001;83(2):235-43.
-
2001: Wagenaar H C; Trimbos J B; Postema S; Anastasopoulou A; van der Geest R J; Reiber J H; Kenter G G; Peters A A; Pattynama P M
Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Gynecologic oncology 2001;82(3):474-82.
-
2001: Trimbos J B; Maas C P; Deruiter M C; Peters A A; Kenter G G
A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(3):180-6.
-
2001: van der Burg S H; Ressing M E; Kwappenberg K M; de Jong A; Straathof K; de Jong J; Geluk A; van Meijgaarden K E; Franken K L; Ottenhoff T H; Fleuren G J; Kenter G; Melief C J; Offringa R
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
International journal of cancer. Journal international du cancer 2001;91(5):612-8.
-
2000: Postema S; Pattynama P M; van den Berg-Huysmans A; Peters L W; Kenter G; Trimbos J B
Effect of MRI on therapeutic decisions in invasive cervical carcinoma. Direct comparison with the pelvic examination as a preperative test.
Gynecologic oncology 2000;79(3):485-9.
-
2000: Hellebrekers B W; Zwinderman A H; Kenter G G; Peters A A; Fleuren G J; Trimbos J B
[Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence]
Nederlands tijdschrift voor geneeskunde 2000;144(48):2304-9.
-
2000: de Leeuw W J; Dierssen J; Vasen H F; Wijnen J T; Kenter G G; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse C J; Morreau H
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
The Journal of pathology 2000;192(3):328-35.
-
2000: Gaarenstroom K N; Kenter G G; Bonfrer J M; Korse C M; Van de Vijver M J; Fleuren G J; Trimbos J B
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gynecologic oncology 2000;77(1):164-70.
-
2000: Ressing M E; van Driel W J; Brandt R M; Kenter G G; de Jong J H; Bauknecht T; Fleuren G J; Hoogerhout P; Offringa R; Sette A; Celis E; Grey H; Trimbos B J; Kast W M; Melief C J
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(2):255-66.
-
2000: Kenter G G; Hellebrekers B W; Zwinderman K H; van de Vijver M; Peters L A; Trimbos J B
The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma.
Acta obstetricia et gynecologica Scandinavica 2000;79(1):72-6.
-
2000: Trimbos J B; Hellebrekers B W; Kenter G G; Peters L A; Zwinderman K H
The long learning curve of gynaecological cancer surgery: an argument for centralisation.
BJOG : an international journal of obstetrics and gynaecology 2000;107(1):19-23.
-
1999: Kersemaekers A M; van de Vijver M J; Kenter G G; Fleuren G J
Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix.
Genes, chromosomes & cancer 1999;26(4):346-54.
-
1999: Koopman L A; Szuhai K; van Eendenburg J D; Bezrookove V; Kenter G G; Schuuring E; Tanke H; Fleuren G J
Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Cancer research 1999;59(21):5615-24.
-
1999: Maas K; Moriya Y; Kenter G; Trimbos B; van de Velde C
A plea for preservation of the pelvic autonomic nerves.
Lancet 1999;354(9180):772-3.
-
1999: van Driel W J; Ressing M E; Kenter G G; Brandt R M; Krul E J; van Rossum A B; Schuuring E; Offringa R; Bauknecht T; Tamm-Hermelink A; van Dam P A; Fleuren G J; Kast W M; Melief C J; Trimbos J B
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial.
European journal of cancer (Oxford, England : 1990) 1999;35(6):946-52.
-
1999: Krul E J; Schipper R F; Schreuder G M; Fleuren G J; Kenter G G; Melief C J
HLA and susceptibility to cervical neoplasia.
Human immunology 1999;60(4):337-42.
-
1999: Kersemaekers A M; Fleuren G J; Kenter G G; Van den Broek L J; Uljee S M; Hermans J; Van de Vijver M J
Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):577-86.
-
1999: van Driel W J; Kenter G G; Fleuren G J; Melief C J; Trimbos B J
Immunotherapeutic strategies for cervical squamous carcinoma.
Hematology/oncology clinics of North America 1999;13(1):259-73.
-
1998: Kersemaekers A M; Kenter G G; Hermans J; Fleuren G J; van de Vijver M J
Allelic loss and prognosis in carcinoma of the uterine cervix.
International journal of cancer. Journal international du cancer 1998;79(4):411-7.
-
1997: Kagie M J; Kenter G G; Zomerdijk-Nooijen Y; Hermans J; Schuuring E; Timmers P J; Trimbos J B; Fleuren G J
Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin.
Gynecologic oncology 1997;67(2):178-83.
-
1997: Kagie M J; Kenter G G; Tollenaar R A; Hermans J; Trimbos J B; Fleuren G J
p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva.
Cancer 1997;80(7):1228-33.
-
1997: Gaarenstroom K N; Bonfrer J M; Korse C M; Kenter G G; Kenemans P
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.
Anticancer research 1997;17(4B):2955-8.
-
1997: Kagie M J; Kenter G G; Tollenaar R A; Hermans J; Trimbos J P; Fleuren G J
p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(2):124-30.
-
1997: Kagie M J; Kenter G G; Hermans J; Trimbos J B; Fleuren G J
The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 1997;7(1):50-7.
-
1996: Kenter G G; Schoonderwald E M; Koelma I A; Arentz N; Hermans J; Fleuren G J
The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist?
Acta obstetricia et gynecologica Scandinavica 1996;75(4):400-3.
-
1995: Gaarenstroom K N; Bonfrer J M; Kenter G G; Korse C M; Hart A A; Trimbos J B; Helmerhorst T J
Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
Cancer 1995;76(5):807-13.
-
1994: Bonfrer J M; Gaarenstroom K N; Kenter G G; Korse C M; Hart A A; Gallee M P; Helmerhorst T J; Kenemans P
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.
Gynecologic oncology 1994;55(3 Pt 1):371-5.
-
1994: Gaarenstroom K N; Kenter G G; Bonfrer J M; Korse C M; Gallee M P; Hart A A; Müller M; Trimbos J B; Helmerhorst T J
Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
Cancer 1994;74(8):2307-13.
-
1993: Kenter G G; Cornelisse C J; Jiwa N M; Aartsen E J; Hermans J; Mooi W; Heintz A P; Fleuren G J
Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis.
Cancer 1993;71(2):397-401.
-
1990: Kenter G G; Cornelisse C J; Aartsen E J; Mooy W; Hermans J; Heintz A P; Fleuren G J
DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.
Gynecologic oncology 1990;39(2):181-5.
-
1989: Kenter G G; Ansink A C; Heintz A P; Aartsen E J; Delemarre J F; Hart A A
Carcinoma of the uterine cervix stage I and IIA: results of surgical treatment: complications, recurrence and survival.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1989;15(1):55-60.
-
1988: Ansink A C; Kenter G G; Heintz A P; Aartsen E J; Delemarre F J; Hart A A
[Stage I and IIa cervix carcinoma; results of radical abdominovaginal excision of the uterus with lymph node dissection and analysis of prognostic factors]
Nederlands tijdschrift voor geneeskunde 1988;132(29):1342-7.
-
1988: Kenter G G; Ansink A C; Heintz A P; Delemarre J; Aartsen E J; Hart A A
Low stage invasive carcinoma of the uterine cervix stage I-IIA morphological prognostic factors.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(2):187-92.
-
1987: Kenter G; Bonfrer J M; Heintz A P
Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.
British journal of cancer 1987;56(2):157-8.
Sign-in to see more